MedInvestGroup opened a nuclear medicine center at Sechenov University for 350 million rubles
Customers: First Moscow State Medical University named after I.M. Sechenov (First Moscow State Medical University) Moscow; Pharmaceuticals, Medicine, Healthcare Contractors: MIG (MedInvestGroup) Project date: 2023/06
|
MedInvestGroup opened the Center for Nuclear Medicine at Sechenov University. The volume of investments in the project amounted to 350 million rubles. This was announced on June 9, 2023.
The new PET/CT diagnostic center for malignant neoplasms is designed to perform up to 10 thousand studies per year. It is equipped with a Discovery 710s positron emission scanner that allows radionuclide studies with the most common radiopharmaceutical fluorodeoxyglucose in 15 - 20 minutes. Residents of Moscow will be able to use the services of a new compulsory medical insurance center.
The Center for Nuclear Medicine, opened on the basis of the First Moscow State Medical University named after I.M. Sechenov, became the fourth such facility "MedInvestGroup" in the capital and the 37th in the federal network of the group. MedInvestGroup opens PET/CT centers and radiation therapy centers throughout Russia. For a number of entities, the company has become one of the largest investors in medical infrastructure, notes the publication "Medical Bulletin."
Earlier 2023 year, a nuclear medicine center with unique equipment was opened at Sechenov University - the SPECT-CT apparatus, which finds foci of pathology or metastases in 10 minutes, saves patients from going to doctors for a long time, so they can quickly get to the operation. In this case, the radiation dose during the study will be minimal.
SPECT-CT NM/CT 860 contains a complete package of programs for the processing of research - there are only three like it in the world. This is a hybrid apparatus that combines the functions of a single-photon emission computed tomograph and a conventional computed tomograph. On it, you can carry out any examination existing today in radionuclide diagnostics and immediately analyze it. Thanks to it, doctors can identify diseases in the thyroid, breast or prostate gland, in the brain, bone, lymphatic systems or myocardium.[1]